Understanding Tumor and Immune Dynamics and Predicting Response to Various Perioperative Therapies in Patients With Muscle-invasive Bladder Cancer
Latest Information Update: 05 Apr 2024
At a glance
- Drugs Pembrolizumab (Primary) ; Sacituzumab govitecan (Primary) ; Nivolumab; Paclitaxel
- Indications Bladder cancer; Urogenital cancer
- Focus Biomarker; Therapeutic Use
Most Recent Events
- 05 Apr 2024 New trial record